升主动脉瘤决策算法的临床有效性评估
本研究基于2011至2017年781例非夹层升主动脉瘤患者,按尺寸和症状算法分诊手术或药物观察。未遵从手术建议者主动脉事件和死亡显著高于药物组,算法能有效识别高危与安全患者。
要点
- 按尺寸和症状分诊可有效识别升主动脉瘤高危患者。
- 未遵从手术建议者主动脉事件发生率13.3% vs 1.7%。
- 未遵从手术建议者死亡率15.6% vs 3.3%。
核心结论
- 基于尺寸和症状的升主动脉瘤手术决策算法在临床中有效,能正确识别高危与安全患者。
- 未遵从手术建议的患者结局显著差于药物观察组。
研究设计与样本
- 回顾性队列研究,纳入2011至2017年781例非夹层升主动脉瘤择期评估患者。
- 按算法分诊手术607例(77%)或药物观察181例(24%),309例未手术。
- 未手术者中128例(16%)被分诊手术但未执行,181例(24%)分诊药物观察。
主要发现
- 未遵从手术组与药物组平均主动脉直径分别为5±0.5 cm与4.45±0.4 cm。
- 主动脉事件(破裂/夹层)在未遵从手术组17例(13.3%),药物组3例(1.7%),P < .001。
- 后期择期手术在未遵从手术组21例(16.4%),药物组15例(8.3%),P = .04。
- 死亡在未遵从手术组20例(15.6%),药物组6例(3.3%),P < .001。
- 未遵从手术组20例死亡中7例死于明确主动脉原因,药物组无。
关键数值与推荐
- 手术指征为动脉瘤>5 cm或有症状。
- 未遵从手术组主动脉事件13.3% vs 药物组1.7%(P < .001)。
- 未遵从手术组死亡15.6% vs 药物组3.3%(P < .001)。
临床怎么用
- 对升主动脉瘤>5 cm或有症状者应按算法推荐手术。
- 需关注未遵从手术建议患者并加强依从性管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The risk of rupture and dissection in ascending thoracic aortic aneurysms increases as the aortic diameter exceeds 5 cm. This study evaluates the clinical effectiveness of a specific algorithm based on size and symptoms for preemptive surgery to prevent complications. METHODS: A total of 781 patients with nondissecting ascending thoracic aortic aneurysms who presented electively for evaluation to our institution from 2011 to 2017 were triaged to surgery (n = 607, 77%) or medical observation (n = 181, 24%) based on a specific algorithm: surgery for large (>5 cm) or symptomatic aneurysms. A total of 309 of 781 patients did not undergo surgery. Of these, 128 (16%) had been triaged to prompt repair but did not undergo surgery for a variety of reasons ("surgery noncompliant and overwhelming comorbidities" group). Another 181 patients (24%) were triaged to medical management ("medical" group). RESULTS: In the "surgery noncompliant and overwhelming comorbidities" versus the "medical" group, mean aortic diameters were 5 ± 0.5 cm versus 4.45 ± 0.4 cm and aortic events (rupture/dissection) occurred in 17 patients (13.3%) versus 3 patients (1.7%), respectively (P < .001). Later elective surgeries (representing late compliance in the "surgery noncompliant and overwhelming comorbidities group" or onset of growth or symptoms in the "medical" group) were conducted in 21 patients (16.4%) versus 15 patients (8.3%) (P = .04), respectively. Death ensued in 20 patients (15.6%) versus 6 patients (3.3%) (P < .001), respectively. In the "surgery noncompliant and overwhelming comorbidities" group, 7 of 20 patients died of definite aortic causes compared with none in the "medical" group. CONCLUSIONS: Patients with ascending thoracic aortic aneurysms who did not follow surgical recommendations experienced substantially worse outcomes compared with medically triaged candidates. The specific algorithm based on size and symptoms functioned effectively in the clinical setting, correctly identifying both at-risk and safe patients.
引用
- Saeyeldin A, Zafar MA, Li Y, et al. Decision-making algorithm for ascending aortic aneurysm: Effectiveness in clinical application? J Thorac Cardiovasc Surg. 2018. PMID: 30579535. doi:10.1016/j.jtcvs.2018.09.124
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。